Home / Inspections / 1273815

FDA Inspection 1273815 — Galephar Pharmaceutical Research Inc.

Galephar Pharmaceutical Research Inc. — FEI 3008206797

The FDA completed an inspection of Galephar Pharmaceutical Research Inc. on June 5, 2025 in Humacao, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 5, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Humacao, PR (United States)

Facility

Other inspections at this facility

  • 1108270 (VAI Fri Nov 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 931265 (VAI Thu Jun 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 814051 (NAI Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 776879 (VAI Mon May 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources